The Fred Hutch Lung Specialized Project of Research Excellence (SPORE) was awarded by the National Cancer Institute in August of 2019 to support groundbreaking research that translates directly into improved prevention, detection, and treatment for patients. The Lung SPORE brings together experts from across Fred Hutch and its partner organizations to fast-track the latest breakthroughs in its labs to patients and those at risk of developing lung cancer.
Working to Improve Immunotherapy for Lung Cancer
NIH Director's Blog | January 30, 2020
'Keeping these out of the hands of adolescents is critical'
Hutch News | November 21, 2019
New program to fast-track lung cancer research from lab to clinic
Hutch News | August 6, 2019
Fred Hutch hosts Seattle Mariners' rising star
Hutch News | January 29, 2019
A blood test for cancer
Science Spotlight | January 21, 2019
A smoky immune response in lung cancer patients
Science Spotlight | November 2017
How cancer fools healthy neighboring cells
Hutch News | July 2017
IDH1 mutant (or methylation), stops monocyte migration
Science Spotlight | June 2017
Understand the immune response before altering it
Science Spotlight | January 2017
Insulin Receptor Substrate-1 now infamous for inflammation
Science Spotlight | September 2016
Good News: New Evergreen Fund to accelerate commercialization of research
Hutch News | December 2016